International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small ...
Anatomic segmentectomy versus lobectomy for clinical stage I non-small cell lung cancer: A propensity-matched analysis. N0321: A phase II study of bortezomib, paclitaxel, carboplatin (CBCDA), and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results